Case report: Successful treatment of recurrent chordoma and bilateral pulmonary metastases following an 11-year disease-free period  by Erkmen, Cherie P. et al.
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INTRODUCTION:  Chordomas  are  rare but aggressive  tumors  due  to local  recurrence  and  distant  metastases.
They  originate  commonly  in  the  sphenooccipital  and  sacrococcygeal  regions,  and  metastasize  to  the lungs,
bone,  skin,  liver,  and lymph  nodes.  They  occur  more  frequently  in  men  and people  over  the  age  of  40.
PRESENTATION OF  CASE:  A  28  year-old  female  presented  with  sacrococcygeal  chordoma  for  which  she
received  wide  local  excision  and  adjuvant  radiation  therapy.  She  enjoyed  an  unusual  disease-free  sur-
vival  for  11  years  until  a routine  surveillance  scan  of the  pelvis  identiﬁed  local  recurrence.  Further  work
up  revealed  bilateral  pulmonary  metastases.  She  underwent  local  excision  of the  recurrent  tumor  and
video-assisted  thoracoscopic  (VATS)  wedge  resection  of  pulmonary  metastases.  She  also  received  adju-
vant  radiation  therapy  to  the  recurrent  resection  bed.  Two  years  later,  she  remains  free  of disease  and
symptoms.
DISCUSSION:  Chordomas  are  commonly  insensitive  to chemotherapy  and  radiation,  making  surgery  the
most  successful  therapeutic  modality.  However,  there  are few guidelines  on  the  surveillance  and  treat-
ment  of  recurrent  chordoma.  We  report  success  with  aggressive  surgical  resection  of  recurrence  and
metastasis  as  well  as  adjuvant  radiation  therapy.
CONCLUSION: The  prolonged  survival  of  our patient  underscores  the importance  of  (1) aggressive  surgical
resection  of chordoma,  whether  primary,  recurrent,  or metastatic,  with  adjuvant  radiation  therapy,  (2)
minimization  of surgical  seeding  of tumor, and (3)  diligent  cancer  surveillance.
©  2014  The  Authors.  Published  by  Elsevier  Ltd. on behalf  of Surgical  Associates  Ltd.  . Introduction
Chordomas are locally invasive, aggressive tumors of noto-
hordal remnants. Chordomas have a general incidence of 0.08 per
00,000 people and constitute 1–4% of all bone cancers.1 They are
specially rare in people younger than 40 and more frequent in
en than women.2 The median survival is 6.29 years with a 10 year
urvival of 39.9%.2 Most primary tumors originate in the cranium
32.0%), spine (32.8%), or sacrum (29.2%).2 Extra-axial metastasis
ccurs in 3–48% of patients.3–5 Complete surgical resection is the
ain modality of treatment. Chordomas are frequently insensi-
ive to chemotherapy and radiation therapy. Local recurrence is
he most important indicator of poor prognosis.6 Metastasis, com-
only occurring in the lungs, liver, bone, lymph nodes, and skin,
s often associated with local recurrence of the primary tumor.5ere, we describe the clinical course and examine the outcomes
f our management of a 39-year-old woman who presented with
∗ Corresponding author. Tel.: +1 603 650 8537; fax: +1 603 650 6346.
E-mail address: Cherie.P.Erkmen@Hitchcock.org (C.P. Erkmen).
ttp://dx.doi.org/10.1016/j.ijscr.2014.02.005
210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associatemultifocal metastases to the lungs and local recurrence in the
gluteal region 11 years after resection of a sacral chordoma.
2.  Presentation of case
2.1.  Primary treatment: aggressive resection with adjuvant
radiation
A  28-year-old woman presented with right buttock discom-
fort increasing over ﬁve years. Physical examination revealed a
ﬁrm, immobile mass posterior to the rectum. MRI  demonstrated
a 20 cm mass originating from the sacrum at the level of S5 and
extending into the gluteus muscles. A CT-guided biopsy of the mass
demonstrated chordoma. The patient underwent en bloc resection
of the tumor and right vertical rectus abdominus myocutaneous
ﬂap for perineal reconstruction. A 6-week course of adjuvant exter-
nal beam radiation therapy (6000 cGy) was administered. Apart
Open access under CC BY-NC-ND license.from occasional fecal incontinence, the patient remained otherwise
asymptomatic for 11 years with no evidence of local recurrence or
metastasis. During this period, she underwent yearly surveillance
abdomen and pelvis contrast enhanced CT scans.
s Ltd. Open access under CC BY-NC-ND license.
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wig. 1. Axial CT slices with arrows indicating (a) local recurrence of chordoma po
artorius muscle, (c) metastatic chordoma nodule in left lower lobe of the lung, and
.2. Wide excision of local recurrence and metastasis with
urative  intent
Eleven  years after her initial diagnosis, surveillance CT of the
bdomen and pelvis identiﬁed a calciﬁed soft tissue density extend-
ng into the right gluteus muscle and a 19 mm fatty density in the
roximal left sartorius muscle (Fig. 1a and b). The abdomen CT also
evealed pulmonary nodules (Fig. 1c and d). A dedicated CT scan of
he chest subsequently identiﬁed four discrete pulmonary lesions:
 19 mm nodule in the right middle lobe, 3 mm nodule in the supe-
ior segment of the right lower lobe, 10 mm nodule in the left lower
obe, and a 10 mm nodule in the left upper lobe. Only the right mid-
le lobe lesion was hypermetabolic by PET scan. Head MRI showed
o evidence of intracranial metastasis. CT guided biopsy of the right
iddle lobe nodule showed metastatic chordoma consistent with
he original sacral chordoma. We  did not biopsy the suspected site
f local recurrence.
Given  the appearance of locally recurrent disease with
ligometastatic disease, we endeavored to resect all suspected foci
f disease with curative intent. In an effort to minimize the num-
er of operations due to the patient’s limited ﬁnancial means while
voiding bilateral lung surgery at the same setting, we planned two
urgeries. The patient ﬁrst underwent video assisted thoracoscopic
urgery (VATS) removal and diagnostic biopsy of the two  left-sided
ulmonary nodules. Both left lung nodules were metastatic chor-
oma resected with negative margins. A month later, the patient
ad wide local excision of right buttock mass, right sartorius mass,
nd VATS resection of two right-sided pulmonary nodules. All lung
pecimens were removed via a retrieval bag (ENDOPOUCH Spec-
men Retrieval Bag System, Ethicon, Cincinnati, OH). The right
uttock mass was dedifferentiated chordoma with a high-grade
pindle cell sarcomatous element and negative margins (Fig. 2).
he sartorius mass was an intramuscular lipoma. The right middle
obe lesion was chordoma with negative margins; the right lower
obe lesion was an intrapulmonary lymph node. The ﬁnal diagnosis
as local recurrence and dedifferentiation of sacral chordoma withr to right gluteus maximus, (b) mass eventually identiﬁed as a lipoma in the left
etastatic chordoma nodule in right middle lobe of the lung.
bilateral pulmonary metastases demonstrating original chordoma
histology. After surgery, the patient received 4600 cGy  of radia-
tion in 200 cGy doses to the region of the recurrent right buttock
chordoma.
2.3. Long-term follow-up
She  is free of disease and symptoms two  years after her recur-
rence with metastases and 13 years after her initial diagnosis of
chordoma. She has continued to undergo surveillance contrast
enhanced CT scans of her chest, abdomen, and pelvis every six
months.
3. Discussion
3.1. Pathological change in local recurrence
Dedifferentiation of chordoma has been reported rarely in local
recurrence, and has been associated with poor prognosis.7–9 It is
unclear if sarcomatous transformation is due to (1) spontaneous
change of the original chordoma, (2) irradiation-induced change, or
(3) polyclonal convergence of two different cancers.9 Our patient
is the ﬁrst known report of dedifferentiated chordoma recurrence
with differentiated chordoma pulmonary metastases. The lung
metastases could have occurred early, before transformation of
the initial chordoma and taken an occult, insidious course, or they
could have evolved from differentiated chordoma cells in a poly-
clonal tumor recurrence. The literature supports the latter scenario
as local recurrence typically precedes metastasis.18
3.2. SurgeryAggressive en bloc surgical treatment has been associated with
decreased local recurrence rates, decreased incidence of metas-
tasis, and overall improved survival.3,10 Since chordomas tend to
be locally destructive tumors, en bloc resection may require tissue
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nig. 2. Pathology H&E stains of gluteal mass showing (a) chordoma cells with chara
f  the tumor (4×), (c) zonal necrosis in the area of the tumor (4×), and (d) tumor in
econstruction.10,11 In our patient, en bloc resection of the sacral
umor with negative tissue margins and reconstruction of her per-
neum led to a long disease free survival after initial treatment. We
herefore advocate aggressive initial surgical resection.
Local recurrence can originate from seeding of the tumor during
iopsy, resection of the primary tumor, or reconstruction.12,13 To
inimize the local recurrence, we recommend (1) wide resection
argins, (2) minimal handling of the tumor, and (3) new instru-
ents, and gloves be used for reconstruction and closure.13 With
ulmonary metastasis, we  advocate a VATS wedge resection with
ide margins and specimen removal via a retrieval bag to prevent
umor contamination of port sites.
.3. Radiation therapy
The  use of radiotherapy to treat primary and secondary chor-
oma is controversial, mitigated by the intolerance of adjacent
pinal cord and brain stem to high radiation doses.14 High dose
adiotherapy with surgery has been proven to favorably affect dis-
ase free interval.15 Conventional radiation therapy at 40–60 Gy
as resulted in 5-year local control of 10–40%.14,16 Our patient was
reated with adjuvant radiation therapy for six months following
nitial resection and also received adjuvant radiation to the site of
ocal recurrence. While the efﬁcacy of adjuvant radiation therapy in
he setting of recurrence is unknown,17 adjuvant radiation therapy
ay be a contributor to her continued long-term survival.
.4.  Follow-up
There are poor evidence-based recommendations on chordoma
atient follow-up. After initial treatment, patients are followed
ith frequent ofﬁce visits in the immediate post-operative period
nd then yearly surveillance abdomen and pelvis CT scans. Clini-
al suspicion for local recurrence should be higher in patients who
nderwent incomplete excision of their original chordoma. Any
ew nodules, ﬁstulas, draining sinuses, or pain and discomfort inic physaliferous cytoplasm and myxoid stroma (20×), (b) lobulated growth pattern
g the bone (4×).
an area even remote from the previous excision warrant investi-
gation for possible recurrence. Local recurrence typically precedes
metastasis.18 Therefore, we recommend that patients with local
recurrence should undergo an evaluation for metastasis with full
body PET/CT scan and head MRI. The role of routine surveillance for
distant metastasis is unknown at this time.
3.5. Treatment of recurrent and metastatic disease
Even with recurrence and metastasis, long-term survival can be
achieved with successful surgical resection of all appreciable dis-
ease, as seen with our patient. Aggressive en bloc resection of the
recurrent tumor with seeding precautions is again preferred. There
are no reports, let alone consensus, about the treatment of pul-
monary metastases in chordoma. We  therefore extrapolated our
experience with other pulmonary metastasis, electing for VATS
wedge resections of each of the pulmonary nodules with negative
margins.19,20 For metastatic chordoma to the lung, we recom-
mend VATS resection if (1) the primary or recurrent tumor can
be completely resected, (2) there are no other metastases, and (3)
the lung metastases can be resected with ample margins without
compromising the patient’s quality of life. Even multiple, bilateral
pulmonary metastases can be aggressively treated with long-term
success.
4. Conclusion
The treatment of chordoma demands both aggressive resection
and cautious attention to minimizing surgical tumor implanta-
tion. Adjuvant therapy is controversial but known to contribute
to long-term disease control and survival. Postoperative patient
follow-up should continue long-term; signs or symptoms consis-
tent with possible local recurrence or metastasis should prompt
a thorough work-up. In the absence of symptoms, surveillance CT
scans can detect potential treatable recurrence. Recurrent disease
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an be treated aggressively with curative intent including surgery
nd adjuvant radiation therapy.
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